HK1076475A1 - Therapeutic uspa1-derived peptides uspa-1 - Google Patents
Therapeutic uspa1-derived peptides uspa-1Info
- Publication number
- HK1076475A1 HK1076475A1 HK05108446.8A HK05108446A HK1076475A1 HK 1076475 A1 HK1076475 A1 HK 1076475A1 HK 05108446 A HK05108446 A HK 05108446A HK 1076475 A1 HK1076475 A1 HK 1076475A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ligand
- uspa1
- uspa
- therapeutic
- derived peptides
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 241000588655 Moraxella catarrhalis Species 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 230000033444 hydroxylation Effects 0.000 abstract 1
- 238000005805 hydroxylation reaction Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0222764.3A GB0222764D0 (en) | 2002-10-02 | 2002-10-02 | Therapeutic peptide |
| PCT/GB2003/004273 WO2004031236A2 (fr) | 2002-10-02 | 2003-10-01 | Peptides therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1076475A1 true HK1076475A1 (en) | 2006-01-20 |
Family
ID=9945111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05108446.8A HK1076475A1 (en) | 2002-10-02 | 2005-09-24 | Therapeutic uspa1-derived peptides uspa-1 |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP1546194B1 (fr) |
| JP (1) | JP4763291B2 (fr) |
| KR (1) | KR101057587B1 (fr) |
| CN (1) | CN1305899C (fr) |
| AT (1) | ATE549348T1 (fr) |
| AU (1) | AU2003299131B2 (fr) |
| BR (1) | BR0315031A (fr) |
| CA (1) | CA2500960A1 (fr) |
| ES (1) | ES2383958T3 (fr) |
| GB (1) | GB0222764D0 (fr) |
| HK (1) | HK1076475A1 (fr) |
| IL (1) | IL167780A (fr) |
| MX (1) | MXPA05003474A (fr) |
| NO (1) | NO20052108L (fr) |
| NZ (1) | NZ539575A (fr) |
| PL (1) | PL376052A1 (fr) |
| WO (1) | WO2004031236A2 (fr) |
| ZA (1) | ZA200503446B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2563332A1 (fr) * | 2004-04-15 | 2005-10-27 | The University Of Bristol | Peptides therapeutiques derives de l'uspa1 |
| KR20080042865A (ko) * | 2005-08-10 | 2008-05-15 | 아르네 포르스그렌 아베 | 모락셀라 카타랄리스와 상피세포, 세포외기질 단백질 및보체계의 상호작용 |
| TW201302779A (zh) | 2011-04-13 | 2013-01-16 | Glaxosmithkline Biolog Sa | 融合蛋白質及組合疫苗 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515467A (ja) * | 1996-12-20 | 2001-09-18 | ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム | モラクセラ・カタラーリスのｕｓｐａ１及びｕｓｐａ２抗原 |
-
2002
- 2002-10-02 GB GBGB0222764.3A patent/GB0222764D0/en not_active Ceased
-
2003
- 2003-10-01 CN CNB2003801017669A patent/CN1305899C/zh not_active Expired - Fee Related
- 2003-10-01 PL PL03376052A patent/PL376052A1/xx not_active IP Right Cessation
- 2003-10-01 CA CA002500960A patent/CA2500960A1/fr not_active Abandoned
- 2003-10-01 KR KR1020057005764A patent/KR101057587B1/ko not_active IP Right Cessation
- 2003-10-01 BR BR0315031-3A patent/BR0315031A/pt not_active IP Right Cessation
- 2003-10-01 NZ NZ539575A patent/NZ539575A/en not_active IP Right Cessation
- 2003-10-01 EP EP03756554A patent/EP1546194B1/fr not_active Expired - Lifetime
- 2003-10-01 ES ES03756554T patent/ES2383958T3/es not_active Expired - Lifetime
- 2003-10-01 EP EP10177682A patent/EP2305700A1/fr not_active Withdrawn
- 2003-10-01 AT AT03756554T patent/ATE549348T1/de active
- 2003-10-01 WO PCT/GB2003/004273 patent/WO2004031236A2/fr active Application Filing
- 2003-10-01 MX MXPA05003474A patent/MXPA05003474A/es active IP Right Grant
- 2003-10-01 AU AU2003299131A patent/AU2003299131B2/en not_active Ceased
- 2003-10-01 JP JP2004540969A patent/JP4763291B2/ja not_active Expired - Fee Related
-
2005
- 2005-03-31 IL IL167780A patent/IL167780A/en not_active IP Right Cessation
- 2005-04-29 ZA ZA200503446A patent/ZA200503446B/en unknown
- 2005-04-29 NO NO20052108A patent/NO20052108L/no not_active Application Discontinuation
- 2005-09-24 HK HK05108446.8A patent/HK1076475A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101057587B1 (ko) | 2011-08-19 |
| JP4763291B2 (ja) | 2011-08-31 |
| ES2383958T3 (es) | 2012-06-27 |
| CN1705678A (zh) | 2005-12-07 |
| NO20052108L (no) | 2005-06-27 |
| CN1305899C (zh) | 2007-03-21 |
| EP1546194B1 (fr) | 2012-03-14 |
| MXPA05003474A (es) | 2005-10-18 |
| ATE549348T1 (de) | 2012-03-15 |
| IL167780A (en) | 2011-05-31 |
| AU2003299131B2 (en) | 2010-04-22 |
| BR0315031A (pt) | 2005-08-16 |
| EP1546194A2 (fr) | 2005-06-29 |
| AU2003299131A1 (en) | 2004-04-23 |
| ZA200503446B (en) | 2006-10-25 |
| NZ539575A (en) | 2006-06-30 |
| CA2500960A1 (fr) | 2004-04-15 |
| EP2305700A1 (fr) | 2011-04-06 |
| GB0222764D0 (en) | 2002-11-06 |
| WO2004031236A3 (fr) | 2004-06-24 |
| WO2004031236A2 (fr) | 2004-04-15 |
| PL376052A1 (en) | 2005-12-12 |
| JP2006516952A (ja) | 2006-07-13 |
| KR20050067410A (ko) | 2005-07-01 |
| NO20052108D0 (no) | 2005-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004024090A3 (fr) | Immunogenes et anticorps correspondant specifiques pour des intermediaires d'agregation de poids moleculaire eleve communs a des amyloides constitues par des proteines de sequences differentes | |
| PL392964A1 (pl) | Antygen reaktywny wobec surowicy hiperimmunologicznej zastosowanie tego antygenu do produkcji preparatu farmaceutycznego, fragment hiperimmunologiczny antygenu, epitopy pomocnicze antygenu, szczepionka zawierająca antygen reaktywny wobec surowicy hiperimmunologicznej, preparat zawierający przeciwciała, sposób wytwarzania tego preparatu, zastosowanie preparatu do leczenia infekcji gronkowcowych oraz sposób przesiewania | |
| DE69638022D1 (de) | Aus wirbeltieren und darauf basierende verfahren | |
| IS6455A (is) | Stöðvun á vexti taugasíma fyrir milligöngu viðtaka Nogo | |
| SE0103754L (sv) | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid | |
| CN101405298A (zh) | 垂体腺苷酸环化酶激活肽(pacap)受体(vpac2)激动剂及其药物使用方法 | |
| NL300830I1 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
| DE68925226D1 (de) | Monoklonale Antikörper | |
| DE69831007D1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
| HK1076475A1 (en) | Therapeutic uspa1-derived peptides uspa-1 | |
| PT996726E (pt) | Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes | |
| WO2005099337A3 (fr) | Peptides therapeutiques | |
| Rajnavölgyi et al. | Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites | |
| AU2003279352B2 (en) | DNA sequence and recombinant production of the grass pollen allergen Phl p4 | |
| EP1760087A4 (fr) | Nouveau complexe proteinique et utilisation de ce complexe | |
| WO2007030771A4 (fr) | Identification ciblee de peptides immunogenes | |
| WO2003064446A3 (fr) | Peptides | |
| EP1467207A4 (fr) | Methode de criblage | |
| ATE329027T1 (de) | Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1 | |
| Conde et al. | Comparative studies of sheep immunoglobulins IgG1 and IgG2: Amino acid sequence of carboxy‐terminal cyanogen bromide fragments from their heavy chains | |
| WO2007042326A3 (fr) | Antigenes de neisseria meningitidis | |
| JP2011037765A (ja) | 新規ペプチド、並びにトリプシン阻害剤、抗インフルエンザウイルス剤、及び抗体 | |
| WO2004005331A3 (fr) | Peptides secretes | |
| DE502008002023D1 (de) | Impfstoff zur Behandlung von Zöliakie und Verfahren zur Herstellung des Impfstoffes, Verwendung einer mit einem bakteriellen Toxin konjugierten Peptidsequenz zur Aktivierung des Immunsystems gegen Prolamine sowie Designerpeptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151001 |